TriangleFOR PATIENTS · SOURCE READING
Treatment of Unresectable, Metastatic, or Recurrent Gallbladder Cancer
Source: Gallbladder Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 10, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.
For information about the treatments listed below, visit the Treatment Option Overview section.
Source links and citations
Treatment of unresectable, metastatic, or recurrent gallbladder cancer is usually within a clinical trial. Treatment may include:
Source links and citations
Percutaneous transhepatic biliary drainage or the placement of stents to relieve symptoms caused by blocked bile ducts. This may be followed by radiation therapy as palliative treatment.
Source links and citations
Surgery as palliative treatment to relieve symptoms caused by blocked bile ducts.
Chemotherapy.
Source links and citations
A clinical trial of new ways to give palliative radiation therapy, such as giving it together with hyperthermia therapy, radiosensitizers, or chemotherapy.
Source links and citations
A clinical trial of targeted therapy or immunotherapy for patients with mutations (changes) in certain genes.
Source links and citations
Use our clinical trial search to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. General information about clinical trials is also available.
Source links and citations
Preserved source evidence · Independent clinical review pending · Not medical advice